542
Views
53
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of primary treatment and loading regimes in the removal of pharmaceuticals and personal care products from urban wastewaters by subsurface-flow constructed wetlands

, , , , , & show all
Pages 632-653 | Received 12 Jan 2010, Accepted 19 Sep 2010, Published online: 16 May 2011
 

Abstract

The ability of several mesocosm-scale horizontal subsurface flow (SSF) constructed wetlands (CW) to remove pharmaceuticals and personal care products (PPCPs) from urban wastewater was assessed in the winter and summer of 2008. As CWs are generally used as secondary or tertiary wastewater treatment systems, their efficacy was compared when fed from two different primary treatment systems, a sedimentation tank and an anaerobic hydrolysis upflow sludge bed reactor (HUSB). The influence of plants (Phragmites australis) in the CWs and their feeding regime (continuous flow or batch flow) on PPCP removal were also monitored. One of the CWs was replicated and operated simultaneously in Barcelona and León, Spain, in order to study the effect of environmental conditions on PPCP removal. All systems operated in the open air. The sedimentation tank offered slightly better removal values throughout the experimental period than the HUSB. The presence of P. australis enhanced the removal of salicylic acid, galaxolide, tonalide and methyl dihydrojasmonate, but only in summer (when plants were more active). The use of a batch flow or a continuous flow made very little difference to PPCP removal efficiency. When the two mesocosm replicates were compared, temperature proved to be one of the most determining parameters affecting PPCP elimination, with naproxen, ibuprofen, diclofenac, caffeine, galaxolide, tonalide and methyl dihydrojasmonate being removed in SSF-CWs more efficiently at higher temperatures. In general, the most easily removed PPCPs in planted CWs were caffeine (14 ± 74%–84 ± 7% in winter, 98 ± 1%–99 ± 1% in summer), methyl dihydrojasmonate (28 ± 21%–63 ± 17% in winter, 93 ± 2%–98 ± 1% in summer) and salicylic acid (0%–97 ± 4% in winter, 41 ± 40%–89 ± 9% in summer), followed by naproxen (0%–41 ± 16% in winter, 60 ± 18%–95 ± 4% in summer) and ibuprofen (0%–47 ± 26% in winter, 35 ± 12%–99 ± 1% in summer). Other substances experimented lower removal efficiencies, like ketoprofen (4 ± 27%–27 ± 14% in winter, 0%–37 ± 32% in summer), diclofenac (0%–22 ± 22% in winter, 0%–71 ± 8% in summer), carbamazepine (0%–9 ± 100% in winter, 0%–58 ± 21% in summer), galaxolide (0% in winter, 25 ± 14%–87 ± 5% in summer) and tonalide (0% in winter, 32 ± 12%–76 ± 12% in summer).

Acknowledgements

This study was funded by the Spanish Ministry of Science and Innovation through Projects CTM2008-06676-C05-03, CTM2008-06676-C05-04 and CTM2008-06676-C05-01, and by the Castilla y León Regional Government through Projects LE009A07 and LE037A10-2. María Hijosa-Valsero acknowledges a fellowship from the Spanish Ministry of Education and Víctor Matamoros acknowledges a Juan de la Cierva contract. We thank Ricardo Sidrach-Cardona Martínez and Eduardo Álvarez for their help during the sampling campaigns.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.